Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621776 · ClinicalTrials.gov registry record · NA

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

A NA study of Type 1 Diabetes, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
107
Enrollment target
1
Study location

NCT01621776: Completed NA study of Type 1 Diabetes, sponsored by University of Florida.

NCT01621776 is a NA study of Type 1 Diabetes that has completed, run by University of Florida. The registered enrollment target is 107 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621776, a NA study of Type 1 Diabetes, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare the post-meal blood glucose values of two drugs in a "real-world" setting.

Primary Outcome

Blood glucose concentrations were measured prior to and 90 minutes following lunch. Analysis was based on intention to treat. While missing data was imputed, it was known that this data was 'not missing at random' thus violating standard statistical assumptions with imputation. Therefore imputed data was not included in the final model. The number of participants for analysis was based upon a convenience sample of individuals attending Florida Camp for Children and Youth with Diabetes at Camp W

Conditions Studied

Interventions

  • DRUG Apidra
  • DRUG Humalog
  • DRUG Novolog

Study Locations (1)

Florida

  • Camp Winona - DeLeon Springs

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2011-06
Est. Completion 2012-08
Phase NA
University of Florida

1,106 total trials

What the finished NCT01621776 record still lists

NCT01621776 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Apidra is the first listed.

NCT01621776 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01621776 about?

NCT01621776 is a clinical study titled "Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia". This study aims to compare the post-meal blood glucose values of two drugs in a "real-world" setting.

What is the current status of trial NCT01621776?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2011-06. Estimated completion is 2012-08.

What conditions does trial NCT01621776 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT01621776?

The interventions under investigation include: Apidra (DRUG), Humalog (DRUG), Novolog (DRUG).

Who is sponsoring clinical trial NCT01621776?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01621776 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01621776's enrollment target sits among peer trials

107 54th of 198 higher than 145 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01621776, the US trial registry maintained by the National Library of Medicine. NCT01621776 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.